Personalized vaccine doubly effective at prolonging lives of women with advanced ovarian cancer
In a University of Pennsylvania study women who received personalized vaccines in combination with chemo had double the two-year survival rate of those treated with chemo alone.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Ovarian Cancer | Ovaries | Study | University of Pennsylvania | Vaccines | Women